Johannesburg - Delayed Quote ZAc

Aspen Pharmacare Holdings Limited (APN.JO)

22,071.00 +428.00 (+1.98%)
At close: April 26 at 5:00 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ZAc.
NameTitlePayExercisedYear Born
Mr. Stephen Bradley Saad BCom, CA(SA) Group CEO & Executive Director 19.04M -- 1964
Mr. Sean M. Capazorio Group CFO & Executive Director 10.36M -- 1967
Ms. Lorraine Hill Group Chief Operations Officer & Responsible Pharmacist 11.17M -- 1964
Mr. Michael Guy Attridge B.Com., CA(SA) Group Chief Advisor 8.4M -- 1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA Group Chief Corporate Services Officer & Executive Director 7.82M -- 1975
Ms. Zizipho Mmango Group Chief Strategic Development Officer 7.82M -- 1985
Sibongakonke Nkosi Investor Relations Manager -- -- --
Mr. Trevor Julian Ziman Regional Chief Executive Officer of Asia Pacific -- -- 1972
Mr. Samer Kassem Chief Executive Officer of Aspen Global Incorporated -- -- 1975
Ms. Raeesa Khan Group Company Secretary -- -- --

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600 https://www.aspenpharma.com
Sector: 
Healthcare
Full Time Employees: 
8,612

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Corporate Governance

Aspen Pharmacare Holdings Limited’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 7; Board: 4; Shareholder Rights: 2; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Sep 20, 2023
    Ex-Dividend Date

Upcoming Events

Mar 05, 2024
Aspen Pharmacare Holdings Limited Earnings Call